Skip to content

Pediatric Asthma Non-invasive Diagnostic Approaches

Pediatric Asthma Non-invasive Diagnostic Approaches - PANDA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55765
Enrollment
80
Registered
2019-03-29
Start date
2019-12-23
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma chronic airway disease

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Between 6-17 years of age - Doctor*s diagnosis of asthma - Treated on asthma GINA treatment step 3 or higher - Signed informed consent from parents (guardians) and children (when applicable) - Dutch speaking

Exclusion criteria

Exclusion criteria: Serious lung disease other than asthma (cystic fibrosis, primary ciliary dyskinesia, congenital lung disorders, severe immune disorders).

Design outcomes

Primary

MeasureTime frame
Differences in clinical characteristics and biomarker profiles between children that remain difficult to treat upon standardized clinical care (based on symptoms, exacerbations and lung function) and children that are controlled.

Secondary

MeasureTime frame
reduction in number of exacerbations improvement in severe asthma questionnaire score improvement in fatigue unsupervised cluster analyses on the -omics data

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)